Targeting Akt may be an essential strategy for tumor prevention and therapy since abnormal Akt overexpression or activation has been shown in several malignancies, including ovarian, lung, and pancreatic cancer, and is related to higher cancer cell growth and survival 15. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.